Development and validation of an extended Cox prognostic model for patients with ER/PR+ and HER2− breast cancer: A retrospective cohort study
Y Xie, X Li, Y Wu, W Cui, Y Liu - World Journal of Surgical Oncology, 2022 - Springer
Background The purpose of this study was to explore a new estrogen receptor (ER) and/or
progesterone receptor (PR)+ and human epidermal growth factor receptor 2 (HER2)− breast …
progesterone receptor (PR)+ and human epidermal growth factor receptor 2 (HER2)− breast …
Prognostic model of ER-positive, HER2-negative breast cancer predicted by clinically relevant indicators
X Song, P Wang, R Feng, M Chetry, E Li, X Wu… - Clinical and …, 2024 - Springer
Purpose To study the clinicopathological variables connected with disease-free survival
(DFS) as well as overall survival (OS) in patients who are ER-positive or HER2-negative and …
(DFS) as well as overall survival (OS) in patients who are ER-positive or HER2-negative and …
Developing and comparing two different prognostic indexes for predicting disease-free survival of nonmetastatic breast cancer patients
To determine 2 different prognostic indexes (PI) for the differentiation of subgroups of
nonmetastatic breast cancer patients with the Cox regression analysis and survival tree (ST) …
nonmetastatic breast cancer patients with the Cox regression analysis and survival tree (ST) …
The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2− Breast Cancer
M Wang, M Zhang, H Chen - Advances in Therapy, 2023 - Springer
Introduction Prognostic prediction based on prognostic stage (PS) with the Oncotype DX
recurrence score (RS) has not been validated in stage III ER+/HER2− breast cancer. This …
recurrence score (RS) has not been validated in stage III ER+/HER2− breast cancer. This …
Developing and comparing two different prognostic indexes for predicting disease-free survival of nonmetastatic breast cancer patients.
Aim: To determine 2 different prognostic indexes (PI) for the differentiation of subgroups of
nonmetastatic breast cancer patients with the Cox regression analysis and survival tree (ST) …
nonmetastatic breast cancer patients with the Cox regression analysis and survival tree (ST) …
Direct comparison of three different mathematical models in two independent datasets of EUSOMA certified centers to predict recurrence and survival in estrogen …
C Iacuzzo, F Giudici, S Scomersi, R Ceccherini… - Breast Cancer Research …, 2021 - Springer
Purpose Prediction algorithms estimating survival rates for breast cancer (BC) based upon
risk factors and treatment could give a help to the clinicians during multidisciplinary …
risk factors and treatment could give a help to the clinicians during multidisciplinary …
[HTML][HTML] Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in HER2-negative Patients Using Shape Restricted Modeling
Purpose To assess the dynamic link between continuous estrogen receptor (ER) expression
and long-term clinical outcomes in non-metastatic breast cancer and to identify the ideal …
and long-term clinical outcomes in non-metastatic breast cancer and to identify the ideal …
A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
A Gunda, MS Eshwaraiah, K Gangappa, T Kaur… - Breast Cancer Research …, 2022 - Springer
Aims Clinicians use multi-gene/biomarker prognostic tests and free online tools to optimize
treatment in early ER+/HER2− breast cancer. Here we report the comparison of recurrence …
treatment in early ER+/HER2− breast cancer. Here we report the comparison of recurrence …
Prognostic significance of young age (< 35 Years) by subtype based on ER, PR, and HER2 status in breast cancer: a nationwide registry‐based study
EK Kim, WC Noh, W Han, DY Noh - World journal of surgery, 2011 - Wiley Online Library
Background Young age is regarded as an adverse prognostic factor in patients with breast
cancer, especially in those with a hormone receptor (HR)‐positive tumor. We investigated …
cancer, especially in those with a hormone receptor (HR)‐positive tumor. We investigated …
Development and Validation of a Prognostic Nomogram for HR+ HER-Breast Cancer
JY Zhou, CG Pan, Y Ye, ZW Li, WD Fu… - Cancer Management …, 2024 - Taylor & Francis
Purpose We aimed to develop a nomogram to predict prognosis of HR+ HER2-breast
cancer patients and guide the application of postoperative adjuvant chemotherapy. Methods …
cancer patients and guide the application of postoperative adjuvant chemotherapy. Methods …
相关搜索
- breast cancer her2 status
- breast cancer prognostic significance
- development and validation prognostic nomogram
- breast cancer recurrence and survival
- breast cancer young age
- breast cancer clinical practice
- prognostic significance her2 status
- breast cancer independent datasets
- breast cancer gene expressions
- breast cancer clinicopathological characteristics
- breast cancer direct comparison